Introduction
Post-procedural elevation of cardiac biomarkers, such as troponin-T (TnT), has been recognized to be a relatively common phenomenon following successful percutaneous coronary interventions (PCIs) [1] [2] [3] [4] . Previous studies have demonstrated that the elevation of TnT predicts long-term mortality [5] [6] [7] . The elevation in TnT is indicative of myocardial injury resulting from a distal embolism or from microvascular obstruction by fragmented thrombi and plaque materials, which can cause no reflow or slow-flow phenomena during PCI 8) . A recent integrated-backscatter intravascular ultrasound (IB-IVUS) study demonstrated that lipid-rich plaques affected post-procedural myocardial injury in patients with stable angina 9) . Although we hypothesized that lesion characteristics, including thrombus, may be predictive factors of embolic complications, the identification of intracoronary thrombus with IB-IVUS is more difficult than with either coronary angioscopy or optical coherence tomography (OCT) 10) . On the other hand, coronary angioscopy can provide lesion characteristics and details, including the existence of thrombus. The purpose of this study was to investigate the relationship between angioscopic lesion characteristics, including thrombus, and the elevation of TnT levels during the peri-procedural phase.
Methods

Study Population
Forty-nine consecutive patients with stable angina who underwent elective coronary stent implantation following angioscopy were enrolled in this study. Stable angina was characterized by patients who showed a positive stress test and had no change in the frequency, duration, or intensity of chest symptoms within 4 weeks. The patients without either new onset, angina at rest, or pre-procedural elevation of TnT were also included. Patients with overt occlusion of the side branch during the PCI procedure (n 2) and stenting for multiple vessels (n 2) were excluded from this study. We also excluded patients with chronic total occlusion (n 3), because of the difficulty of determining plaque characteristics angioscopically. Finally, 42 patients were analyzed in this study. The study protocol was approved by the Ethics Committee of our institution, and the patients gave informed consent for participation and data collection.
Procedure of Elective Stenting
All patients had a single de novo lesion with 75% diameter stenosis in a native coronary artery and underwent successful stenting. All patients received anti-platelet agents (aspirin 100 or 200 mg/day and ticlopidine 200 mg/day) for at least 7 days prior to stent implantation, and 100 IU/ kg heparin just before stenting. No patients received glycoprotein b/ a receptor inhibitors, which are not approved for use in Japan. All procedures were performed using 7-French guiding catheters by the femoral approach. The physician decided on the position and length of the angioplasty and stent implantation according to angiograms. Successful PCI was defined as 25% residual stenosis with no occlusion of the large branch and final grade 3 flow according to the TIMI grading system. Flow complications were defined as either slow flow or no reflow. Slow flow was defined as TIMI grade 1 or 2 flow during the procedure and no reflow was defined as TIMI grade 0 flow during the procedure.
Angiographic Analysis
The angiography results were evaluated by an independent investigator who was not involved in the PCI procedures. A computerized quantitative analysis system (CMS, Medis Medical Imaging System, Nuenen, The Netherlands) was used with a guiding catheter for calibration. Angiographic measurements included the reference diameter, minimum lumen diameter, percent diameter stenosis, and lesion length.
Coronary Angioscopic Procedure
Coronary angioscopy was performed using a 7-Fr guiding catheter and an image catheter (Vecmova Neo; FiberTech Co., Chiba, Japan). Before use, the white balance was adjusted for color correction. The light power was adjusted to avoid reflections and to determine the color of the plaque and the thrombus. Angioscopic images were recorded on digital videotape for later review.
Definition and Analysis of Angioscopic Findings
Angioscopic observations of the culprit plaque were performed just before PCI. The plaque color, complexity, and presence of thrombus were evaluated. The plaque color was classified as either intense yellow or not intense yellow (white or light yellow) (Fig. 1) . The plaque complexity was defined as a smooth surface (simple plaque) or an irregular surface (complex plaque). The thrombus was defined as a coalescent red, white, or mixed (white and red) intraluminal, superficial, or protruding mass adhering to the vessel surface but was clearly a separate structure that persisted despite flushing with saline solution 11) . The angiographic and angioscopic images were analyzed separately by two experienced investigators who were blinded to clinical information. Agreement between observers was measured by having an observer repeat the assessment of 20 images (presented in random order) a week later. Inter-observer agreement was measured by comparing the assessment of 42 images by the two observers. Intra-observer agreements for the evaluated items (thrombus, yellow plaque and complex plaque) were 95%, 100% and 95%, respectively. Inter-observer agreements of those items were 95%, 95% and 95%, respectively. In case of disagreement, the observers reached a consensus by discussion.
Evaluation of Cardiac Biomarkers and Blood Examination
Blood was sampled prior to the PCI procedure and every 8 hours until 24 hours following the procedure. The serum TnT was measured using an enzyme immunoassay kit (Roche Diagnostics, Tokyo, Japan). The detection limit of this system is 0.01 ng/mL. Peak post-procedural values were used for analysis. Postprocedural myocardial injury was defined as an ele-vated TnT level ≥ 0.03 ng/mL at any time points after the procedure, based on studies that have defined this level as optimal for the prediction of mortality 12) . This cut-off value was also based on the ESC/ACC/AHA/ WHF definition of myocardial infarction (MI), which defines a post-procedural MI, among patients with normal pre-procedural values, as an increase in biomarker value that is ≥ 3 times the upper limit of normal (99th percentile) 13) . The patients were divided into two groups, including a group with post-procedural myocardial injury (injury group) and a group without post-procedural myocardial injury (no-injury group). Moreover, the levels of high-density lipoprotein cholesterol (HDL-C), creatinine, and high sensitive C-reactive protein (hs-CRP) were also measured at baseline levels, and low-density lipoprotein cholesterol (LDL-C) was calculated using Friedwald's formula.
Statistics
Continuous variables are expressed as the mean SD values. Comparisons between the two groups were performed with the unpaired Student's t -test. Comparisons of categorical variables presented as numbers (percentages) were performed by either the 2 test or with Fisher's exact test. Multivariate logistic regression analysis was used to determine the factors associated with elevated TnT levels in patients with elective PCI. Independent variables included in the analysis were classic coronary risk factors, serum hs-CRP and LDL-C levels, and the angioscopic findings. We set the level of statistical significance at p 0.05.
Results
Patient, Lesion, and Procedural Characteristics
Intense yellow plaque was found in 24 patients (57%) and post-procedural myocardial injury occurred in 22 patients (52%). The clinical variables for the study population are shown in Table 1 . There were no significant differences in baseline clinical characteristics between the injury group and the no-injury group. Lesion and procedural characteristics are summarized in Table 2 . QCA analysis revealed that total stent length was significantly longer in the injury group than in the no-injury group (22.6 6.1 mm vs. 15.5 3.9 mm, p 0.02). In addition, no significant differences were observed in the frequency of pre-dilatation, the maximum pressure of inflation, or the total inflation time between the two groups. The mean duration of statin administration was 5 4 months.
Association between Angioscopic Findings and Post-Procedural Myocardial Injury
Angioscopic observations before PCI were successfully obtained from all patients. The frequency of intense yellow color plaques was significantly higher in the injury group than in the no-injury group (91% vs. 20%, p 0.001), while no significant difference was seen in the presence of the thrombus between the two groups (Fig. 2) . All thrombi were mural red thrombi. The frequency of the complex plaque was also significantly higher in the injury group than in the no-injury group (55% vs. 5%, p 0.007). Multivariate linear regression analysis demonstrated that the intense yellow color of the culprit plaque and total stent length were associated with the elevation of serum TnT levels after elective PCI (p 0.01) in Table 3 . 
Relationship between Slow Flow and Intense Yellow Plaque
The incidence of transient slow flow in patients in the injury group was significantly higher than in the no-injury group (23% vs. 0%, p 0.049) (Fig . 3) . Final angiograms showed neither occlusion nor slow flow of major side branches. All patients with transient slow flow had intense yellow plaques. The final flow grade improved to TIMI 3 in all slow-flow patients by intracoronary injection of sodium nitroprusside.
Discussion
The current study suggested that intense yellow plaque formation was closely related to the elevation of serum TnT levels after elective stenting. A recent study showed that a larger volume and lipid-rich plaque on IB-IVUS might be indicative of post-procedural myocardial injury in elective PCI 9) . Intense yellow plaques upon angioscopic examination correlated with the presence of a plaque with a large lipid area on IB-IVUS display 14) . Postmortem histological assessment and in vivo studies with other coronary imaging devices, such as virtual histology IVUS and OCT, have shown that yellow color intensity is associated with a lipid core underneath a thin fibrous cap and that intense yellow plaques might be structurally vulnerable [15] [16] [17] . Similarly, it has been reported that nonintense yellow plaque was plaque with a thick fibrous cap 17) . It is reasonable to assume that lipid components contained by intense yellow plaque under a thin fibrous cap are more easily released by stent dilatation in comparison with non-intense yellow plaque under a thick fibrous cap; therefore, the mechanical disruption of intense yellow plaques by stent implantation may possibly lead to distal embolization and myocardial injury.
Continuous strong-statin therapy for 12 months leads to a masked reduction of LDL-C levels and a yellow color of coronary plaques at non-culprit lesions 18) . In other words, aggressive LDL-C lowering (around 100 mg/dL) changed the average plaque color to light yellow, not intense yellow in this study. Although the majority of patients in this study received statins and overall LDL-C levels were almost identicalto the previous study, angioscopic observation of the culprit lesions of stable angina identified intense yellow plaques in more than half of the cases (57%). This may appear surprising; however, the current target plaques located in the culprit lesions differed from non-culprit plaques in the previous study. In addition, the period of statin therapy for the patients was relatively short and may be insufficient to reduce the color of yellow plaque.
In our series, we found post-procedural myocardial injury in 52% of patients as an elevation of the TnT level ≥ 0.03 ng/mL. The proportion of post-procedural myocardial injury was higher than in the previous report, accounting for 11% 9) . The cut-off value of TnT in the previous study was 0.3 ng/mL, and different definitions of post-procedural myocardial injury may explain these discrepancies. Although final angiograms showed neither occlusion nor slow flow of major side branches, myocardial injury due to blocked side branches of small diameter may affect the results and lead to a relatively high frequency of post-procedural myocardial injury in the current study.
In the present study, complex plaques were also associated with post-procedural TnT elevation. Ruptured plaque has been reported to be related to distal embolization by stenting 19) ; therefore, this finding corresponded with our results. However, plaque complexity was not significantly higher in multivariate analysis than intense yellow plaque because the intense yellow plaque did not necessarily correspond with either plaque complexity or thrombus. Disrupted yellow plaque with thrombus formation is occasionally observed in asymptomatic patients as well as stable angina 20) . Only intense yellow plaque is therefore considered to influence post-procedural myocardial injury among patients with stable angina.
According to a previous study, intracoronary thrombi accounted for PCI-related myocardial damage;8 however, the existence of thrombus was not associated with post-procedural elevation of TnT levels in this study. Although ruptured yellow plaques and intracoronary massive thrombi in the culprit plaques of acute coronary syndrome were frequently observed in a previous study 21) , there were no massive thrombi in this study because all patients had stable angina pectoris and only mural thrombi. A previous study suggested plaque debris to more strongly influence both the slow-flow phenomenon and distal embolization after stenting than thrombi 19) . As a result, mural thrombi are not considered to likely be either a powerful predictor or to have the ability to induce post-procedural myocardial injury in cases of In this study, the frequency of pre-dilatation, maximum pressure inflation and the total inflation time were not found to influence post-procedural myocardial injury, while the total stent length was associated with post-procedural myocardial injury. Large plaque burden is a powerful predictor of postprocedural myocardial injury according to volumetric analysis using IVUS 9) . Combination study with angioscopy and gray-scale IVUS showed that the presence of yellow plaques is correlated with positive remodeling of coronary arteries 22) . Therefore, intense yellow plaques, which are partly equivalent to thin-cap fibroatheromas identified by OCT or IVUS [15] [16] [17] , may have a large plaque burden. Also, diffuse long lesions possibly have a large plaque burden since long stent implantation as well as stenting for intense yellow plaques may cause post-procedural myocardial injury. These results therefore suggested that plaque volume reduction is closely associated with distal embolization by longer stenting.
In the present study, the transient slow-flow phenomenon was observed in 12% of patients, all of which had intense yellow plaques and showed postprocedural increases in TnT. There are several possible mechanisms explaining the slow-flow phenomenon. One potential mechanism is that acute microvascular obstruction is caused by distal embolization of plaque debris, mainly lipid components. Another mechanism may involve impaired microcirculation by vascular constriction, thus resulting from the release of vascular contracting factors, such as serotonin 23) . Generally, serotonin is a vasoactive substance contained in the dense granules of circulating platelets, platelet deposition sites, and sites of activation and arterial damage induced by vascular trauma, including PCI. It has been reported that serotonin released into the coronary circulation following PCI causes an increase in vascular tone with a significant decrease in the regional blood flow 24) . Atherosclerotic vulnerable plaques, such as intense yellow plaques, may more easily release serotonin in comparison to non-intense yellow plaques 25) . In this study, flow complications might have been only transient slow flow, and persistent slow-flow and no-reflow phenomena were not identified in any cases. All patients had already received statin treatment before they underwent elective PCI in the present study. As previously shown, statin therapy may be The frequency of intense yellow color plaques and plaque complexity was significantly higher in the injury group than in the no-injury group, while there were no significant differences in the presence of thrombus between the two groups. The incidence of transient slow flow in patients in the injury group was significantly higher than in the no-injury group. All patients with transient slow flow had intense yellow plaques.
useful for preventing persistent slow flow after coronary stenting 26) . An increase in post-procedural TnT correlated with a worse mid-term or long-term clinical outcome 5-7, 12, 27-30) . Despite minor increases in the levels of TnT following PCI, this phenomenon could be an important adverse event. High-risk plaques, prone to forming micro-embolizations, may be identified by coronary angioscopy. Unexpectedly, we encountered either slow-flow or no-reflow situations even in patients with stable angina. On the basis of angioscopic findings, surgeons should therefore be aware of the possibility of distal embolization after stenting. Angioscopic information on the culprit plaque may enable the use of a distal protection device or intracoronary drug injections with agents such as nicorandil, nitroprusside, or adenosine to prevent the occurrence of either slow flow or no reflow after stenting 8) . There were several limitations to this study. Our findings were based on observations in a relatively small number of patients. Angioscopic evaluation of the lipid target plaque volume was impossible. Nevertheless, angioscopic observations demonstrated detailed features of culprit plaques, including complexity and thrombus.10, 11 Further investigation is expected to clarify whether post-procedural myocardial injury after PCI affects the long-term clinical outcome, such as mortality, left ventricular dysfunction, and heart failure.
In conclusion, intense yellow coloration of the culprit plaque was associated with TnT elevation and transient slow flow following elective coronary stenting. Our study suggests that angioscopic yellow plaques might be high-risk indicators for post-procedural myocardial injury.
